First comprehensive genomic study of common cold reveals new treatment targets
The common cold's immune response, not the virus itself, causes symptoms, according to a comprehensive genomic study. The research identifies therapeutic targets that can balance the immune response and potentially prevent infection.
SourceProcter & Gamble·JournalAmerican Journal of Respiratory and Critical Care Medicine·DateOct 24, 2008